BOSTON, March 28, 2023 (GLOBE NEWSWIRE) — Block & Leviton is investigating Harmony Biosciences Holdings, Inc. HRMY for potential securities law violations. Investors who have lost money on their investment in Harmony Biosciences should do so contact the company to learn more about how to make up for those losses. For more information, see https://www.blockleviton.com/cases/hrmy.

Why is?

On March 28, 2023, short seller Scorpion Capital released an investigative report on Harmony Biosciences claiming that Harmony’s “$175,000-a-year drug” had “alarming toxicity,” “no efficacy,” “bogus patents,” and “fraud.” “based on clinical trials” and was “driven via false advertising and a huge off-label and doctor kickback program”.

Following the release of the report, Harmony Biosciences shares fell more than 20% in early morning trade on March 28, 2023.

Who is Eligible?

Anyone who has bought Harmony Biosciences Holdings, Inc. stock and lost money may be eligible, whether they have sold their investment or not. Investors should contact Block & Leviton for more information.

What does Block & Leviton do?

Block & Leviton is investigating whether the company has violated securities laws and may file a lawsuit to try to recover losses on behalf of investors who have lost money.

What should you do next?

If you’ve lost money on your investment, you should contact Block & Leviton to learn more about ours case website, by email at cases@blockleviton.comor by calling (617) 398-5600.

Why should you contact Block & Leviton?

Many law firms may issue press releases on this subject; Most of these firms do not conduct securities class actions. Block & Leviton is a law firm that actually hears cases. We are committed to obtaining significant recoveries on behalf of defrauded investors through active litigation in federal courts across the country. Many of the country’s leading institutional investors entrust us with representing their interests. You can…